Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A robustness-based approach to systems-oriented drug design.

Hiroaki Kitano1

  • 1Sony Computer Science Laboratories Inc., 3-14-13 Higashi-Gotanda, Shinagawa, Tokyo 141-0022, Japan. kitano@sbi.jp

Nature Reviews. Drug Discovery
|February 24, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Odor-specific olfactory stimulation is associated with selective transcriptional changes and partial improvement of stress-evoked bladder overactivity in mice.

Frontiers in neuroscience·2026
Same author

Creating an engine of scientific discovery, an Indo-Japan perspective: learnings from IJNTC 2025 workshop.

NPJ systems biology and applications·2026
Same author

Outplaying elite table tennis players with an autonomous robot.

Nature·2026
Same author

The future of fundamental science led by generative closed-loop artificial intelligence.

Frontiers in artificial intelligence·2026
Same author

Fair human-centric image dataset for ethical AI benchmarking.

Nature·2025
Same author

Noninvasive, label-free image approaches to predict multimodal molecular markers in pluripotency assessment.

Scientific reports·2024
Same journal

R&D productivity trends for biopharma companies in Asia and emerging markets.

Nature reviews. Drug discovery·2026
Same journal

Growth in clinical research capability in China and impact on the pharmaceutical sector.

Nature reviews. Drug discovery·2026
Same journal

Circular RNA guides exon skipping in DMD.

Nature reviews. Drug discovery·2026
Same journal

p38α inhibition restores axonal transport.

Nature reviews. Drug discovery·2026
Same journal

Inflammatory bowel disease-on-a-chip.

Nature reviews. Drug discovery·2026
Same journal

Designing GPCR-targeted miniproteins.

Nature reviews. Drug discovery·2026
See all related articles

Many drugs fail due to biological robustness. A systems-oriented approach, using engineering principles, could improve drug design by better controlling cellular robustness for more effective treatments.

Area of Science:

  • Systems biology
  • Pharmacology
  • Control theory

Background:

  • Many targeted drugs show limited efficacy or cause side effects.
  • The inherent robustness of biological systems often counteracts drug effects.
  • Understanding system-level properties is crucial for effective drug development.

Purpose of the Study:

  • To explore the concept of biological robustness in drug development.
  • To propose a theoretical foundation for a systems-oriented drug design approach.
  • To illustrate how considering robustness can improve drug efficacy and reduce side effects.

Main Methods:

  • Analysis of existing drug examples to illustrate robustness.
  • Application of control and communication theories from engineering.

Related Experiment Videos

  • Modeling of complex biological network systems.

    • Main Results:

    • Biological systems exhibit significant robustness against perturbations.
    • Targeted therapies may fail due to this inherent robustness.
    • A systems-oriented approach can provide a framework for designing more robust drugs.

    Conclusions:

    • Drug development must account for biological system robustness.
    • Engineering principles can inform the design of novel therapeutics.
    • A shift towards systems-level drug design could enhance therapeutic success.